Switzerland-WHO Statement/AstraZeneca

AstraZeneca COVID-19 vaccine, blood clots link "plausible but not confirmed": WHO

  • English
  • Français
  • العربية
  • Pусский
  • Español
  • 日本語
  • Deutsch

Shotlist


Beijing, China - April 8, 2021 (CCTV - No access Chinese mainland)
1. Screenshot of World Health Organization (WHO) statement

FILE: Geneva, Switzerland - Date Unknown (WHO - Access All)
2. Various of WHO headquarters

Beijing, China - April 8, 2021 (CCTV - No access Chinese mainland)
3. Screenshot of agenda of European Medicines Agency (EMA) press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of COVID-19 Vaccine AstraZeneca and thromboembolic events

FILE: Brussels, Belgium - Jan 17, 2018 (CCTV - No access Chinese mainland)
4. EU flags

FILE: Brussels, Belgium - Oct 18, 2019 (CCTV - No access Chinese mainland)
5. European Council building
6. Sign of European Council

FILE: Nairobi, Kenya - 2020 (CGTN - No access Chinese mainland)
7. Flag of AstraZeneca

FILE: Bristol, UK - 2021 (CGTN - No access Chinese mainland)
8. Various of medical worker preparing for vaccination with AstraZeneca vaccine
9. Various of elderly woman being inoculated with AstraZeneca vaccine

FILE: Shanghai, China - Date Unknown (CCTV - No access Chinese mainland)
10. Sign reading (Chinese/English) "AstraZeneca"
11. Information board showing slogans of AstraZeneca

FILE: London, UK - Jan 12, 2021 (CCTV - No access Chinese mainland)
12. Tower Bridge
13. Empty street
14. Various of pedestrians, buildings

FILE: Stockholm, Sweden - Dec 11, 2018 (CGTN - No access Chinese mainland)
15. Cruise ship
16. Riverside buildings

FILE: Reykjavik, Iceland - Oct 2, 2019 (CCTV - No access Chinese mainland)
17. Various of traffic on street

Storyline


A causal link between the AstraZeneca COVID-19 vaccine and the rare occurrence of blood clots with low platelets is "considered plausible but not confirmed," the World Health Organization (WHO) said on Wednesday.

Earlier on the day, the European Medicines Agency (EMA) confirmed that the cases of blood clots with low blood platelets were associated with the administration of the AstraZeneca COVID-19 vaccine, but should still be listed as very rare side effects.

In an interim statement, the WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that the events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca vaccine around the world.

However, specialized studies are needed to fully understand the potential link, and the GACVS said it will continue to gather and review further data.

Meanwhile, the GACVS added that rare adverse events following immunizations should be assessed against the risk of deaths from COVID-19 and the potential of the vaccines to prevent infections and reduce deaths. According to the WHO's statistics, as of Wednesday, at least 2.6 million people have died of COVID-19 worldwide.

Several European countries have already halted or suspended the rollout of the AstraZeneca vaccine in view of the reported risks. On Wednesday, the WHO said that the side effects, mostly mild and local in nature, are "expected" and "common" within two or three days following vaccination.

It also recommended that individuals who experience any severe symptoms, such as shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms such as severe and persistent headaches or blurred vision, tiny blood spots under the skin beyond the site of the injection, from around four to 20 days following vaccination should seek urgent medical attention.

"In extensive vaccination campaigns, it is normal for countries to identify potential adverse events following immunization," the GACVS said. "This does not necessarily mean that the events are linked to the vaccination itself, but they must be investigated to ensure that any safety concerns are addressed quickly.

"Vaccines, like all medicines, can have side effects. The administration of vaccines is based on a risk versus benefit analysis," it added.

DOWNLOAD
  • ID : 8186492
  • Dateline : April 8/7, 2021
  • Location : Switzerland;China
  • Category : health
  • Duration : 1'30
  • Audio Language : Nats/Part Mute
  • Source : China Central Television (CCTV),China Global Television Network (CGTN)
  • Restrictions : No access Chinese mainland
  • Published : 2021-04-08 05:58
  • Last Modified : 2021-04-08 16:25:11
  • Version : 1
  • ID : 8186492
  • Dateline : 8/7 avr. 2021
  • Location : Suisse;Chine
  • Category : health
  • Duration : 1'30
  • Audio Language : Nats/Partiellement muet
  • Source : China Central Television (CCTV)
  • Restrictions : Pas d’accès dans la partie continentale de Chine
  • Published : 2021-04-08 15:42
  • Last Modified : 2021-04-08 16:25:11
  • Version : 1
  • ID : 8186492
  • Dateline : 7/8 ابريل 2021
  • Location : سويسرا;الصين
  • Category : health
  • Duration : 1'30
  • Audio Language : الصوت الطبيعي/صامت جزئيا
  • Source : China Central Television (CCTV),China Global Television Network (CGTN)
  • Restrictions : No access Chinese mainland
  • Published : 2021-04-08 15:56
  • Last Modified : 2021-04-08 16:25:11
  • Version : 1
  • ID : 8186492
  • Dateline : 8/7 апр 2021
  • Location : Швейцария;Китай
  • Category : health
  • Duration : 1'30
  • Audio Language : Естественный звук/Частично немое
  • Source : China Central Television (CCTV)
  • Restrictions : Недоступно материковой части Китая
  • Published : 2021-04-08 15:41
  • Last Modified : 2021-04-08 16:25:11
  • Version : 1
  • ID : 8186492
  • Dateline : 7/8 abr. 2021
  • Location : Suiza;China
  • Category : health
  • Duration : 1'30
  • Audio Language : Nats/Parte Muda
  • Source : China Central Television (CCTV)
  • Restrictions : No acceso a la parte continental de China
  • Published : 2021-04-08 16:19
  • Last Modified : 2021-04-08 16:25:11
  • Version : 1
  • ID : 8186492
  • Dateline : 2021年4月8/7日
  • Category : health
  • Duration : 1'30
  • Audio Language : 自然音声/一部音声なし
  • Source : China Central Television (CCTV)
  • Restrictions : 中国大陸での使用は不可
  • Published : 2021-04-08 14:20
  • Last Modified : 2021-04-08 16:25:11
  • Version : 1
  • ID : 8186492
  • Dateline : 8./7. April 2021
  • Category : health
  • Duration : 1'30
  • Audio Language : Originalton/ Teilweise ohne Ton
  • Source : China Central Television (CCTV),China Global Television Network (CGTN)
  • Restrictions : Für das chinesische Festland nicht verfügbar
  • Published : 2021-04-08 16:10
  • Last Modified : 2021-04-08 16:25:11
  • Version : 1

Switzerland-WHO Statement/AstraZeneca

AstraZeneca COVID-19 vaccine, blood clots link "plausible but not confirmed": WHO

Dateline : April 8/7, 2021

Location : Switzerland;China

Duration : 1'30

  • English
  • Français
  • العربية
  • Pусский
  • Español
  • 日本語
  • Deutsch


Beijing, China - April 8, 2021 (CCTV - No access Chinese mainland)
1. Screenshot of World Health Organization (WHO) statement

FILE: Geneva, Switzerland - Date Unknown (WHO - Access All)
2. Various of WHO headquarters

Beijing, China - April 8, 2021 (CCTV - No access Chinese mainland)
3. Screenshot of agenda of European Medicines Agency (EMA) press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of COVID-19 Vaccine AstraZeneca and thromboembolic events

FILE: Brussels, Belgium - Jan 17, 2018 (CCTV - No access Chinese mainland)
4. EU flags

FILE: Brussels, Belgium - Oct 18, 2019 (CCTV - No access Chinese mainland)
5. European Council building
6. Sign of European Council

FILE: Nairobi, Kenya - 2020 (CGTN - No access Chinese mainland)
7. Flag of AstraZeneca

FILE: Bristol, UK - 2021 (CGTN - No access Chinese mainland)
8. Various of medical worker preparing for vaccination with AstraZeneca vaccine
9. Various of elderly woman being inoculated with AstraZeneca vaccine

FILE: Shanghai, China - Date Unknown (CCTV - No access Chinese mainland)
10. Sign reading (Chinese/English) "AstraZeneca"
11. Information board showing slogans of AstraZeneca

FILE: London, UK - Jan 12, 2021 (CCTV - No access Chinese mainland)
12. Tower Bridge
13. Empty street
14. Various of pedestrians, buildings

FILE: Stockholm, Sweden - Dec 11, 2018 (CGTN - No access Chinese mainland)
15. Cruise ship
16. Riverside buildings

FILE: Reykjavik, Iceland - Oct 2, 2019 (CCTV - No access Chinese mainland)
17. Various of traffic on street


A causal link between the AstraZeneca COVID-19 vaccine and the rare occurrence of blood clots with low platelets is "considered plausible but not confirmed," the World Health Organization (WHO) said on Wednesday.

Earlier on the day, the European Medicines Agency (EMA) confirmed that the cases of blood clots with low blood platelets were associated with the administration of the AstraZeneca COVID-19 vaccine, but should still be listed as very rare side effects.

In an interim statement, the WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that the events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca vaccine around the world.

However, specialized studies are needed to fully understand the potential link, and the GACVS said it will continue to gather and review further data.

Meanwhile, the GACVS added that rare adverse events following immunizations should be assessed against the risk of deaths from COVID-19 and the potential of the vaccines to prevent infections and reduce deaths. According to the WHO's statistics, as of Wednesday, at least 2.6 million people have died of COVID-19 worldwide.

Several European countries have already halted or suspended the rollout of the AstraZeneca vaccine in view of the reported risks. On Wednesday, the WHO said that the side effects, mostly mild and local in nature, are "expected" and "common" within two or three days following vaccination.

It also recommended that individuals who experience any severe symptoms, such as shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms such as severe and persistent headaches or blurred vision, tiny blood spots under the skin beyond the site of the injection, from around four to 20 days following vaccination should seek urgent medical attention.

"In extensive vaccination campaigns, it is normal for countries to identify potential adverse events following immunization," the GACVS said. "This does not necessarily mean that the events are linked to the vaccination itself, but they must be investigated to ensure that any safety concerns are addressed quickly.

"Vaccines, like all medicines, can have side effects. The administration of vaccines is based on a risk versus benefit analysis," it added.

ID : 8186492

Published : 2021-04-08 05:58

Last Modified : 2021-04-08 16:25:11

Source : China Central Television (CCTV),China Global Television Network (CGTN)

Restrictions : No access Chinese mainland

More



Login
Username
Password
code
Sign In
OK